The University serves Virginia, the nation, and the world by preparing responsible citizen-leaders; advancing, preserving, and disseminating knowledge; and providing world-class patient care.
All gifts of any kind help secure the University’s place as a premier institution of learning and make it possible for our students, faculty, and researchers to shape a brighter future.
You can give to all 12 schools across Grounds. The possibilities are endless for supporting our students, faculty, and programs. Together, we will find the way forward.
You can join the growing number of alumni and friends who invest now in the University’s future by including UVA as a beneficiary of their wills, charitable trusts, and retirement plans. Gifts like these can offer you and your family significant tax benefits as well as greater financial flexibility in meeting your personal and philanthropic goals.
Through Honor the Future, the largest in University history, concluded in 2025, thanks to thousands of loyal supporters. Its impact on students, faculty, facilities, and research reaches across Charlottesville, Wise County, and Northern Virginia as it continues to advance the school into the third century of service to the commonwealth, nation, and world.
Generous alumni and friends, grateful patients, community members, foundations, and visionary philanthropists came together to help UVA Health surpass its $1 billion fundraising goal, benefiting every aspect of UVA Health’s mission.
With your help we’ve raised
0 from 0 donors
The campaign has enhanced all areas of UVA Health, an academic health system encompassing UVA Health University Medical Center, the UVA Schools of Medicine and Nursing, the UVA Claude Moore Health Sciences Library, three community hospitals, and an integrated network of primary and specialty care clinics throughout Virginia. Your support is advancing the organization’s patient care, research, education, and community outreach missions.
Philanthropic investments in patient-care programs and facilities include support for:
For Olivia Goodwin, UVA Health Children’s is a lifesaver. Expanding our NICU and PICU will save more children.
Transformative investments in UVA Health’s laboratory, translational, and clinical research programs include:
Harrison Center director John Lukens is collaborating on promising advances in neurodegenerative disease research.
The Paul and Diane Manning Institute of Biotechnology will catalyze the discovery and development of groundbreaking new treatments and cures for cancer, neurodegenerative and autoimmune diseases, and many other health conditions. It will train and foster interdisciplinary research among next-generation physician-investigators, medical leaders, microbiologists, biomedical engineers, chemists, and data scientists. Together, they will accelerate the creation of immunotherapies, gene and cellular therapies, nanomedicines, and other leading-edge precision treatments. The institute will also serve as an incubator of commercial collaborations among UVA, biotechnology companies, academic partners, and healthcare institutions across the state.
The Manning Institute was made possible by a $100 million lead gift from Paul and Diane Manning. Additional investments include $150 million from the University, $100 million from the Commonwealth of Virginia, and more than $50 million in commitments from private donors. “Our goal is to have the best possible medicine—next-generation medicine—for the residents of Virginia and people around the globe,” said Paul Manning.
Under construction in Fontaine Research Park, the 350,000-square-foot facility will integrate high-tech research laboratories, state-of-the-art manufacturing capabilities, and patient-care spaces under one roof. At the same time, UVA is developing a statewide clinical trials network to expand access to new treatments as they are being developed and tested.
Mark T. Esser (Med ’98) is the Manning Institute’s head and chief scientific officer and a Thomas A. Saunders III Family Jefferson Scholars Foundation Distinguished University Professor. Esser’s specialties include immunology, vaccines and biologic drugs, virology and microbiology, diagnostics and biomarkers, clinical research and development, business development, and navigating federal research regulations and submissions.
Once completed, the Manning Institute building will also house UVA’s Institute for Nanoscale Scientific and Technological Advanced Research under the leadership of preeminent nanotechnology scholar Evan Scott. Scott joined UVA in 2024 as a professor of biomedical engineering in the School of Medicine and the School of Engineering and Applied Science. He is the David Goodman Family Bicentennial Professor in Nanomedicine and a Thomas A. Saunders III Family Jefferson Scholars Foundation Distinguished University Professor.
When renowned biomedical researcher Evan Scott uses the term “life-changing” to describe his move to Charlottesville as well as the collaborative discoveries fostered by nanoSTAR, the UVA nanotechnology institute he leads, he isn’t exaggerating. Both have been transformative.
In 2022, UVA Comprehensive Cancer Center became Virginia’s first National Cancer Institute-designated Comprehensive Cancer Center. This prestigious NCI designation positioned UVA among the country’s best cancer treatment and research institutions. It reflected the center’s more than a decade of growth and achievements in cancer care, research, and education, as well as its efforts to reduce the burden of cancer in a region of approximately 3.2 million people and 87 counties, including predominantly rural and under-resourced areas of West Virginia and Southwestern Virginia. The center is helping increase access to world-class cancer care and clinical trials at UVA Health’s Emily Couric Clinical Cancer Center building in Charlottesville, as well as at additional clinics throughout Northern and Central Virginia.
Under the leadership of director Dr. Thomas P. Loughran Jr., the F. Palmer Weber-Smithfield Foods Professor of Oncology Research, the center helped recruit approximately 100 world-class faculty researchers and physicians to UVA. These leading experts, including biomedical engineers, microbiologists, cancer immunologists, and specialists and subspecialists in all types of cancer, conduct interdisciplinary basic, clinical, and population research to improve cancer prevention, diagnosis, and treatment options.
UVA Comprehensive Cancer Center comprises over 250 researchers and physician-investigators from 25 academic departments across the schools of Medicine, Nursing, Data Science, Engineering, Arts & Sciences, and Education and Human Development. In addition to discovering and developing more effective and less invasive cancer interventions, these faculty members are training the next generation of cancer experts to make tomorrow’s breakthroughs. Recent recruits include Kristin Anderson, an assistant professor in the Department of Microbiology, Immunology, and Cancer Biology at UVA School of Medicine. The center helped to recruit Anderson with support from the Rodger W. Klein Family Fund.
In support of the University’s Grand Challenges: Precision Medicine/Health research initiative, UVA Comprehensive Cancer Center drives the discovery and development of new precision medicines and techniques, including immunotherapies, gene and cellular therapies, and nanomedicines. It’s also making these new life-saving treatments available to more patients more quickly by expanding its capacity to run clinical trials, including the first-in-human (phase 1) trials of experimental medicines.
In partnership with UVA Health and the Charlottesville-based Focused Ultrasound Center, UVA Comprehensive Cancer Center helped establish the world’s first and only Focused Ultrasound Cancer Immunotherapy Center at the University. Combining immunotherapy with focused ultrasound—an innovative precision soundwave imaging technology—has been found to overcome existing limitations of immunotherapy and may open new fronts in the war against breast and brain tumors and many other types of cancer.
With the support of a visionary donor, the center launched the Translational Orphan Blood Cancer Research Initiative (TOBCRI), which focuses on reducing the burden of leukemias, lymphomas, and myelomas, including the rare (orphan) and most complex types of these diseases. The initiative has generated six new experimental drugs that could be available to patients within two years, and more are in the research and development pipeline. Many of the TOBCRI’s inventions leverage nanotechnology, utilizing tiny nanostructures to enhance the delivery and efficacy of precision-targeted drugs, gene therapies, and immunotherapies. With its state-of-the-art laboratory, manufacturing, and clinical spaces, the Paul and Diane Manning Institute of Biotechnology will accelerate and increase the availability of these promising precision treatments for patients in Virginia and beyond.
Read More
Campaign support for UVA Health’s educational mission includes:
DECISIONS, DECISIONS
A generous financial aid package and scholarship enable Harrison Cook to keep his options open.
Harrison Cook (Med ’26) Recipient of the Ron Ohslund Medical Scholarship
+
For Harrison Cook, the goal is “to keep my horizon as broad as I can.” Given his wide-ranging interests, from orthopedics to cardiology to nephrology, it’s easy to understand why.
An anatomy class and the chance to shadow a neurosurgeon during high school sparked Cook’s interest in medicine. Exploring how complex structures fit together in a cadaver lab made him sure he wanted to become a doctor. He enjoyed microbiology and his master’s research in endocrinology. Yet over time, he said, “I found that I was really missing the human connection. I love interacting with people, and the thing that I love about medicine is the ability to use science and directly apply these fundamental principles of science in a way that you can help people in their day-to-day lives.”
The first in his family to pursue medicine, Cook said they were completely behind his decision, yet they did not have the resources to assist him financially. Faced with supporting himself and the prospect of mounting debt, he was awarded UVA’s maximum financial aid package, which he said covers roughly half of his costs to attend. The scholarship he received added to a level of support he described as “astounding” and which directly expanded his options.
“The resources that I very gratefully received while I’ve been at UVA have given me the freedom to pursue my interests in medicine in a very honest way,” he explained. “I don’t feel the pressure to pursue the most high-paying specialty or the specialty with a short residency program that will allow me to get a higher salary at an earlier age and start paying my debt down, because I’ve had these factors.”
Although Cook is deferring a final decision on his career path, he is not waiting to give back. As part of a student-run organization that provides community health screenings in Charlottesville and surrounding rural areas, Cook is already practicing both the clinical and “people” skills that drew him to medicine. He said he is happy to answer clinical questions and practice medical skills but also just to get to know patients as people.
“Through that time of just talking to people in a very casual way, you can really gain insight into who they are as a person, what their values are,” he said, “and a lot of clinical insight can come out of those conversations.”
DANCER TURNED RESEARCHER
“I feel so profoundly grateful for the Conway scholarship because it truly makes all of this possible. I could not pursue my Ph.D. and my research without the support.”
Molly Yeo (Nurs ’24, Grad Arts & Sciences ’31) Conway Scholar
Meet Molly Yeo. Former professional ballet dancer. Die-hard Mets fan. A “Third Culture Kid” who grew up between New York, North Carolina, and Indonesia who speaks Indonesian. Bachelor of Science in Nursing Class of 2024 graduate, a distinguished major, mentee of nurse scientist Emma Mitchell, and an emerging cancer scholar whose research on men and the HPV vaccine whet her appetite to enroll in the Ph.D. program.
READ MORE
Rachel Conner-Gorby shares the gift of gratitude for support she received as a Conway Scholar in the School of...
Alumna and Conway Scholar Keli Presley (Ed ’23, Nurs ’25) returns to Grounds.
SECOND ACT
A finance executive turned nurse educator, Laurel Geis discovered her true calling through her children’s health challenges—and now she’s inspiring the next generation to find theirs in healthcare.
Laurel Geis (Nurs ’19) Clinical Faculty and graduate of the Clinical Nurse Leader program
Your dream career may not always be your first career. Laurel Geis found her calling later in life. Now, she steers the next generation toward healthcare—early on.
Geis, originally from the Golden State’s San Gabriel Valley, majored in business at the University of Southern California and then worked in finance and operations for 20 years—first at the Big Four accounting firm Arthur Andersen, and then, helping her mom run a recruiting business. “And along the way, I started a family and had four beautiful kids,” she recalled. “It was only when my kids started having health challenges that I began to be more interested in healthcare. As these different challenges came up, I realized I really needed to be the primary health advocate for myself and my kids.”
Philanthropic contributions to UVA Health’s community outreach program include:
UVA School of Nursing students are learning that care goes beyond treatment and diagnosis to ensuring the health of our communities.
UVA nurses take their expertise on the road to reach more patients in Charlottesville.
